IMPORTANT DATES
13 November 2026 / Congress Start Date 14 November 2026 / Congress End Date 16 October 2026 / Registration & Accommodation Early Bird Deadline 13 November 2026 / Congress Start Date 14 November 2026 / Congress End Date 16 October 2026 / Registration & Accommodation Early Bird Deadline

SCIENTIFIC PROGRAM

TIME HALL 1
07.00-08.00 Continental Breakfast
08.00-08.10 Opening Remarks and Summit Objectives
  SESSION I: Indication and timing for PVR
Moderators:
Panelists:
08.10-08.50 LIVE CASE 1
08.50-08.57 Dysfunction in conduits and BPVs; indication for intervention
08.57-09.02 Indication for intervention in native RVOT with TAP
09.02.09.09 The role MR angiography and how to evaluate it
09.09-09.16 Discussion
09.16-09.30 Debate: Timing in the PVR;
Pro: keep the current guidelines,
Con: be more proactive (5 minutes each talk, Rebuttal: 2 minutes each),
09.30-10.10 LIVE CASE 2
10.10-10.25 COFFEE BREAK
  SESSION II: Imaging for patient selection and planning of the procedure
Moderators:
Panelists:
10.25-10.32 Is there any role of the CT angiography in planning of TPVR in conduit
10.32-10.39 The role of CT angiography for planning of TPVR in large RVOT; how to interpret it
10.39-10.46 Is there any role of the 3D printed models and advanced imaging?
10.46-11.00 Discussion
11.00-11.14 Debate: Advancing imaging is necessary at least CT/3D reconstruction
Pro: … , Con: …… (5 minutes each talk, Rebuttal: 2 minutes each)
11.14-12.00 LIVE CASE 3
12.00-13.15 LUNCH BREAK: Take your lunchbox and meet the masters of the valves; Learn how to select the pt and how to implant, and consult your cases Room A. Venus-P valves Room B. Alterra AS and Sapien valves Room C. Pulsta Valves
13.15-15.15 SESSION III: Procedural tips and tricks in conduits and BPVs Moderators: Panelists:
13.15-14.00 LIVE CASE 4
14.00-14:07 When and how to do CC test before prestenting
14.07-14:14 Pre-stenting of the conduits; tips and tricks
14:14-14:21 tPVR in small conduits; how small is too small
14:21-14:28 How to implant VIV into BPVs; when and how to fracture it
14:28-15.00 Discussion
15.00-15.15 COFFEE BREAK
15.15-16.40 SESSION IV: TPVR in large native RVOT Moderators: Panelists:
15.15-16.00 LIVE CASE 5
15.40-15.47 BE valves in large native RVOT (Sapien and Myval)
15.47-15.54 Harmony valve in large native RVOT
15.54-16.01 Venus-P valve in large native RVOT
16.01-16.08 Pulsta valve in large native RVOT
16.08-16.15 Alterra AS for native RVOT
16.15-16.22 Med-Zenith PT-Valve
16.22-16.30 Discussion
16.30-16.40 COFFEE BREAK
16.40-18.02 SESSION V: Controversy session in native RVOT Moderators: Panelists:
16.40-17.20 LIVE CASE 6
17.20-17.34 Pre-stenting is essential before BE valve implantation in native RVOT
Pro: ……;
Con: …… (5 minutes each talk, Rebuttal: 2 minutes each),
17.34-17.48 Coronary compression test must be done in native RVOT
Pro: ……;
Con: …… (5 minutes each talk, Rebuttal: 2 minutes each),
17.48-18.02 Balloon sizing is essential in every native RVOT vs absolutely not in all
Pro: ……;
Con: …… (5 minutes each talk, Rebuttal: 2 minutes each),
19.30-22.00 GALA DINNER/BOSPHORUS CRUİSE
TIME HALL 1
07.00-08.00 Continental Breakfast
SESSİON VI. Advantages, disadvantages and limitations of the available valves in the market
Moderators:
Panelists:
08.00-08.40 LIVE CASE 7
08.40-08.45 Melody valve
08.45-08.50 Sapien valve
08.50-08.55 Myval-Meril
08.55-09.00 Venus-P valve
09.00-09.05 Harmony valve
09.05-09.10 Alterra AS with Sapien valve
09.10-09.20 Discussion
09.20-10.00 LIVE CASE 8
10.00-10.15 COFFEE BREAK
SESSİON VII. Prevention and management of complications
Moderators:
Panelists:
10.15-10.22 In pre-stenting of conduits
10.22-10.29 In pre-stenting of native RVOT
10.29-10.36 During BE valve implantations
10.36-10.43 During SE valve implantation
10.43-11.00 Discussion
11.00-11.15 Debate: for avoiding from the high risky percutaneous procedure In too large and aneurysmal RVOT/MPA Pro: I would prefer surgical PVR with RVOT reconstruction Con: I would prefer hybrid tPVR, no need reconstruction
11.15-12.00 LIVE CASE 9
12.00-13.00 LUNCH BREAK: Take your lunchbox and meet the masters of the valves;
Learn how to select the pt and how to implant, and consult your cases
Room A. Harmony and Melody valve
Room B. Meril-Myval THV
Room C. Med-Zenith PT valve
SESSİON VIII. Follow-up and mid-long-term results of the TPVs Moderators:
Panelists:
13.00-13.40 LIVE CASE 10
13.40-13.47 İnfective endocarditis; diagnosis, treatment and management
13.47-13.54 HAM and HALT: are they clinically important in TPVs?
13.54-14.01 Durability of TPVs in the conduits and BPVs; the risk and mode of the dysfunctions
14.01-14.08 Durability of TPVs in native RVOT; the risk and mode of the dysfunctions
14.08-14.15 Reinterventions; VIV implantation into the dysfunctional TPVs; when and how
14.15-14.25 Discussion
14.25-14.40 Debate: The risk of İnfective endocarditis
Pro: It differs from valve-to-valve
Con: It differs according to the nature of the RVOT (5 minutes each talk, Rebuttal: 2 minutes each), 14.40-15.20 LIVE CASE 11, Site: …..,, Operators: …. 15.20-15.35 COFFEE BREAK
SESSİON VIII. Interesting-extreme cases in PPVI (6 cases will be selected among the sent)
Moderators:
Panelists:
15.35-16.35 7 minutes presentation, 3 minutes discussion for each case
16.35-17.15 LIVE CASE 12
17.15-17.30 Keynote lecture: where we are in tPVI and future of the tPVI
17.30 Closure remarks